Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment.
Sevcikova K, Zhuang Z, Garcia-Manero G, Alvarez RH, Kantarjian HM, Mego M, Albarracin C, Tang G, Strom SS, Medeiros LJ, Hortobagyi GN, Reuben JM, Khoury JD. Sevcikova K, et al. Among authors: hortobagyi gn. Leukemia. 2016 Jan;30(1):242-7. doi: 10.1038/leu.2015.122. Epub 2015 May 15. Leukemia. 2016. PMID: 25975189 No abstract available.
Breast cancer.
Buzdar AU, Hortobagyi GN. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer Chemother Biol Response Modif. 1999;18:435-69. Cancer Chemother Biol Response Modif. 1999. PMID: 10800497 Review. No abstract available.
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.
Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D, Valero V, Arun B, Ibrahim N, Rivera E, Royce M, Cleeland CS, Hortobagyi GN. Pusztai L, et al. Among authors: hortobagyi gn. Cytokine. 2004 Feb 7;25(3):94-102. doi: 10.1016/j.cyto.2003.10.004. Cytokine. 2004. PMID: 14698135 Clinical Trial.
Expression of sigma 1 receptor in human breast cancer.
Wang B, Rouzier R, Albarracin CT, Sahin A, Wagner P, Yang Y, Smith TL, Meric-Bernstam F, Marcelo Aldaz C, Hortobagyi GN, Pusztai L. Wang B, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 2004 Oct;87(3):205-14. doi: 10.1007/s10549-004-6590-0. Breast Cancer Res Treat. 2004. PMID: 15528963
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.
Symmans WF, Fiterman DJ, Anderson SK, Ayers M, Rouzier R, Dunmire V, Stec J, Valero V, Sneige N, Albarracin C, Wu Y, Ross JS, Wagner P, Theriault RL, Arun B, Kuerer H, Hess KR, Zhang W, Hortobagyi GN, Pusztai L. Symmans WF, et al. Among authors: hortobagyi gn. Endocr Relat Cancer. 2005 Dec;12(4):1059-69. doi: 10.1677/erc.1.01051. Endocr Relat Cancer. 2005. PMID: 16322343
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits.
Yang CH, Gonzalez-Angulo AM, Reuben JM, Booser DJ, Pusztai L, Krishnamurthy S, Esseltine D, Stec J, Broglio KR, Islam R, Hortobagyi GN, Cristofanilli M. Yang CH, et al. Among authors: hortobagyi gn. Ann Oncol. 2006 May;17(5):813-7. doi: 10.1093/annonc/mdj131. Epub 2006 Jan 10. Ann Oncol. 2006. PMID: 16403809 Free article. Clinical Trial.
1,106 results